Trelia J. Craft

566 citations

16 papers · 323 indexed · h-index 9

Co-authors: Gerald F. Smith Jeffrey K. Smallwood Philip W. Iversen Brian J. Eastwood Neil W. DeLapp Mark W. Farmen Leonard C. Weir Michael R. Wiley
Topics: Blood Coagulation and Thrombosis Mechanisms (12 papers)Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers)Protease and Inhibitor Mechanisms (4 papers)
Cited by: Hematology Dermatology Cancer Research
Journals: Circulation Biochemical and Biophysical Research Communications Journal of Medicinal Chemistry
Partner nations: United States United Kingdom

In The Last Decade

Trelia J. Craft

16 papers receiving 293 citations

Peers

Countries citing papers authored by Trelia J. Craft

Since Specialization

Citations

This map shows the geographic impact of Trelia J. Craft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trelia J. Craft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trelia J. Craft more than expected).

Fields of papers citing papers by Trelia J. Craft

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trelia J. Craft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trelia J. Craft. The network helps show where Trelia J. Craft may publish in the future.

Co-authorship network of co-authors of Trelia J. Craft

This figure shows the co-authorship network connecting the top 25 collaborators of Trelia J. Craft. A scholar is included among the top collaborators of Trelia J. Craft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trelia J. Craft. Trelia J. Craft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Investigation of the terminal P4 domain in a series of d-phenylglycinamide-based factor Xa inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),John J. Masters,(unknown),Valentine J. Klimkowski,Michael Chouinard,(unknown),Lea M. Johnson,David W. Snyder,(unknown),Trelia J. Craft,Richard D. Towner,Donetta S. Gifford‐Moore,Larry L. Froelich,Jeffrey K. Smallwood,(unknown),Gerald F. Smith,John W. Liebeschuetz,Christopher W. Murray,Stephen Young	1
2	d-Phenylglycinol-derived non-covalent factor Xa inhibitors: Effect of non-peptidic S4 linkage elements on affinity and anticoagulant activity 2007 ·Bioorganic & Medicinal Chemistry Letters ·Valentine J. Klimkowski,Brian M. Watson,Michael R. Wiley,John W. Liebeschuetz,(unknown),(unknown),(unknown),Daniel J. Sall,Jeffrey K. Smallwood,(unknown),Gerald F. Smith,(unknown),Trelia J. Craft,(unknown),(unknown),Scott M. Sheehan	6
3	The Minimum Significant Ratio: A Statistical Parameter to Characterize the Reproducibility of Potency Estimates from Concentration-Response Assays and Estimation by Replicate-Experiment Studies 2006 ·SLAS DISCOVERY ·Brian J. Eastwood,Mark W. Farmen,Philip W. Iversen,Trelia J. Craft,Jeffrey K. Smallwood,(unknown),Neil W. DeLapp,Gerald F. Smith	100
4	Investigation of factor Xa inhibitors containing non-amidine S1 elements 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),John J. Masters,Jennifer M. Tinsley,Trelia J. Craft,Larry L. Froelich,Donetta S. Gifford‐Moore,Valentine J. Klimkowski,Jeffrey K. Smallwood,Gerald F. Smith,(unknown),(unknown),Leonard C. Weir,Michael R. Wiley	6
5	N²-Aroylanthranilamide Inhibitors of Human Factor Xa 2000 ·Journal of Medicinal Chemistry ·Ying K. Yee,(unknown),(unknown),Douglas W. Beight,Trelia J. Craft,Donetta S. Gifford‐Moore,Theodore Goodson,David K. Herron,Valentine J. Klimkowski,Jeffrey A. Kyle,J. Scott Sawyer,Gerald F. Smith,Jennifer M. Tinsley,Richard D. Towner,Leonard C. Weir,Michael R. Wiley	35
6	A Family of Arginal Thrombin Inhibitors Related to Efegatran 1996 ·Seminars in Thrombosis and Hemostasis ·Gerald F. Smith,Robert T. Shuman,Trelia J. Craft,(unknown),K D Kurz,Noel D. Jones,Nickolay Y. Chirgadze,Róbert Hermann,(unknown),George Sandusky,(unknown),Charles V. Jackson	16
7	D-Phe-Pro-p-Amidinobenzylamine: A potent and highly selective thrombin inhibitor 1996 ·Bioorganic & Medicinal Chemistry Letters ·Michael R. Wiley,Nickolay Y. Chirgadze,David K. Clawson,Trelia J. Craft,Donetta S. Gifford‐Moore,Noel D. Jones,Jennifer L. Olkowski,Leonard C. Weir,Gerald F. Smith	33
8	N-substituted glycines as replacements for proline in tripeptide aldehyde thrombin inhibitors 1995 ·Bioorganic & Medicinal Chemistry Letters ·Aaron L. Schacht,Michael R. Wiley,Nickolay Y. Chirgadze,David K. Clawson,Trelia J. Craft,(unknown),Noel D. Jones,(unknown),Jennifer L. Olkowski,Robert T. Shuman,Gerald F. Smith,Leonard C. Weir	6
9	Serine protease selectivity of the thrombin inhibitor D-Phe-Pro-Agmatine and its homologs 1995 ·Bioorganic & Medicinal Chemistry Letters ·Michael R. Wiley,Nickolay Y. Chirgadze,David K. Clawson,Trelia J. Craft,Donetta S. Gifford‐Moore,Noel D. Jones,Jennifer L. Olkowski,Aaron L. Schacht,Leonard C. Weir,Gerald F. Smith	28
10	Pharmacodynamics of modified tissue plasminogen activator LY210825 in the conscious dog as evaluated with immunocapture assays 1993 ·Fibrinolysis and Proteolysis ·Gerald F. Smith,Trelia J. Craft,(unknown)	1
11	Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis. 1992 ·Journal of Pharmacology and Experimental Therapeutics ·Charles V. Jackson,Joseph D. Frank,Trelia J. Craft,(unknown),Gerald F. Smith	6
12	Characterization of LY806303 as a potent and selective inhibitor of thrombin 1992 ·Bioorganic & Medicinal Chemistry Letters ·Daniel J. Sall,(unknown),(unknown),Trelia J. Craft,(unknown),Donetta S. Gifford‐Moore,(unknown),Gerald F. Smith	1
13	Thrombolytic activity of a novel plasminogen activator, LY210825, compared with recombinant tissue-type plasminogen activator in a canine model of coronary artery thrombosis. 1990 ·Circulation ·Charles V. Jackson,(unknown),Trelia J. Craft,(unknown),Brian W. Grinnell,Jesse L. Bobbitt,P. J. Burck,(unknown),Gerald F. Smith	23
14	Topographics of dry skin, non-dry skin, and cosmetically treated dry skin as quantified by skin profilometry 1985 ·Journal of the Society of Cosmetic Chemists ·(unknown),Trelia J. Craft	15
15	Quantification of the skin's topography by skin profilometry 1982 ·International Journal of Cosmetic Science ·(unknown),Trelia J. Craft,(unknown),(unknown),(unknown)	27
16	Heparin reacts stoichiometrically with thrombin during thrombin inhibition in human plasma 1976 ·Biochemical and Biophysical Research Communications ·Gerald F. Smith,Trelia J. Craft	19

About Trelia J. Craft

Trelia J. Craft is a scholar working on Hematology, Genetics and Cancer Research, having authored 16 papers that have together received 323 indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (12 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Protease and Inhibitor Mechanisms (4 papers). The work is most often cited by research in Hematology (109 citations), Dermatology (27 citations) and Cancer Research (45 citations). Trelia J. Craft has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Gerald F. Smith, Jeffrey K. Smallwood, Philip W. Iversen, Brian J. Eastwood, Neil W. DeLapp, Mark W. Farmen, Leonard C. Weir, Michael R. Wiley, Donetta S. Gifford‐Moore and Noel D. Jones. Their work appears in journals such as Circulation, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact